tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Timothy Chiang, 58 are a BUY (92.06%), 3 are a HOLD (4.76%), 2 are a SELL (3.17%).
Analyst Timothy Chiang works at CAPITAL ONE with a stock forecast success ratio of 35.56% fulfilled within 183.36 days on average.
Timothy Chiang’s has documented 158 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IRWD, Ironwood Pharmaceuticals at 02-Sep-2022.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 6/15/2018. The price target of $120 was fulfilled within 4 days with a profit of $17.71 (17.31%) receiving and performance score of 43.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
71
$29.95 (72.96%)
41
8 months 10 days ago
10/11 (90.91%)
$8.79 (14.13%)
337
Buy
70
$28.95 (70.52%)
44
8 months 25 days ago
2/3 (66.67%)
$8.35 (13.54%)
105
Hold
44
$2.95 (7.19%)
40
11 months 2 days ago
5/5 (100%)
$1.03 (2.40%)
86
Buy
33
$-25.16 (-43.26%)
24
2 years 1 months 8 days ago
3/3 (100%)
$-1.3 (-3.79%)
375
Hold
3 years 9 months 10 days ago
2/2 (100%)
$5.8 (47.54%)
224
What Year was the first public recommendation made by Timothy Chiang?
